Appetite suppressants and valvular heart disease - a systematic review.
about
Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individualsRisk of valvular heart disease associated with use of fenfluraminePharmacotherapies for obesity: past, current, and future therapiesSerotonergic drugs and valvular heart diseaseDrugs and dilated cardiomyopathies: A case/noncase study in the French PharmacoVigilance Database.Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended eventLorcaserin Administration Decreases Activation of Brain Centers in Response to Food Cues and These Emotion- and Salience-Related Changes Correlate With Weight Loss Effects: A 4-Week-Long Randomized, Placebo-Controlled, Double-Blind Clinical Trial.Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action.Pulmonary hypertension, hyperthyroidism, and fenfluramine: a case report and review.Lorcaserin (Belviq): A Selective Serotonin 5-HT2C Agonist In the Treatment of Obesity.Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons.Cardiovascular safety of low-dose fenfluramine in Dravet syndrome: a review of its benefit-risk profile in a new patient population.Cardiac effects of MDMA on the metabolic profile determined with 1H-magnetic resonance spectroscopy in the rat.
P2860
Q21245270-4782C115-44AD-407C-BFFB-AA1687C1F20FQ21261946-C9B92D0F-F54F-4ABA-82E4-4E0D60C6CA49Q21296814-3C2F8D2D-A854-42EE-83FD-CA727A358EACQ24646869-82226C2B-71CA-41CB-8423-87379AF1E6EAQ33692818-49F7E784-BA9D-4803-B7DD-B767FAF76B62Q34254787-C5BEA12F-FBD8-4AC6-87AA-04F8E5CA7B24Q34533195-B0949A6B-A3B2-4FD3-9CD2-93219A482A85Q34962263-6BAEAA9A-92A7-49CE-A48F-591A26E7561EQ36784255-FA4075BE-41FE-4384-9793-42741F812AD8Q37310802-59EE4AA2-E8A9-491A-BA22-80B5B441A7FCQ38031743-8F876005-39DE-409E-B16E-81F0F83E0573Q38681023-529CCC30-7727-4975-ACA2-C8BE5BF35701Q40950605-9B7F3D40-D824-4119-957F-2BD527FAD337
P2860
Appetite suppressants and valvular heart disease - a systematic review.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Appetite suppressants and valvular heart disease - a systematic review
@nl
Appetite suppressants and valvular heart disease - a systematic review.
@ast
Appetite suppressants and valvular heart disease - a systematic review.
@en
type
label
Appetite suppressants and valvular heart disease - a systematic review
@nl
Appetite suppressants and valvular heart disease - a systematic review.
@ast
Appetite suppressants and valvular heart disease - a systematic review.
@en
prefLabel
Appetite suppressants and valvular heart disease - a systematic review
@nl
Appetite suppressants and valvular heart disease - a systematic review.
@ast
Appetite suppressants and valvular heart disease - a systematic review.
@en
P2860
P31
P356
P1476
Appetite suppressants and valvular heart disease - a systematic review.
@en
P2093
Angharad Pritchard-Copley
Yoon K Loke
P2860
P2888
P356
10.1186/1472-6904-2-6
P407
P50
P577
2002-08-23T00:00:00Z
P5875
P6179
1002212633